Fundraising Fox
/Companies
Sign in

Verndari

Napa, US · Founded 2015 · Delaware corporation

Find your way into Verndari

Sign up to see every warm intro you have to Verndari

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Verndari team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Verndari develops the VaxiPatch, a single-dose vaccination kit that uses intradermal microarray technology for vaccine delivery. The company focuses on vaccine delivery methods designed to be pain-free and thermostable, with pre-clinical studies indicating higher efficacy than traditional delivery.

BiotechHealthtechMedical Devices

Founders & leadership

Verndari was founded in 2015 by Daniel R. Henderson.

DRDaniel R. Henderson
Daniel R. HendersonChief Executive Officer, Chief Scientific Officer, Co-Founder2015–2025
JHJohn H. Brown
John H. BrownPresident

Board

JA
Jan A. Van ProoyenBoard director

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 1 round · 2016

▶$1.6MraisedFeb 2017 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John H. BrownExecutive Officer
  • Daniel R. HendersonExecutive Officer, Director
  • Jan A. Van ProoyenDirector
Offering amount
$2M
Amount sold
$1.6M
Minimum investment
$1
First sale
Jan 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

VandriaVandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics. The company's management team specializes in mitochondrial function and neurological disease treatment.

Companies working in the same space as Verndari.

In the news

Contact - Verndari Incverndariinc.com · May 2023

Frequently asked questions

What does Verndari do?
Verndari develops the VaxiPatch, a single-dose vaccination kit that uses intradermal microarray technology for vaccine delivery. The company focuses on vaccine delivery methods designed to be pain-free and thermostable, with pre-clinical studies indicating higher efficacy than traditional delivery.
Who founded Verndari?
Verndari was founded by Daniel R. Henderson in 2015.
How much funding has Verndari raised?
Verndari has disclosed $1.6M raised across 1 round.
Where is Verndari headquartered?
Verndari is headquartered in Napa, US.